Duloxetine
| Material: | 1 ml serum (Blood taken at baseline prior to next dose) |
| Methods: | Flüssigkeitschromatographie-Massenspektrometrie (LC-MS/MS) → LC-Tandem-Massenspektrometrie |
| Indication | Therapeutic drug monitoring |
| Therapeutic range | 30 – 120 µg/l > 240 µg/l toxic |
| Please note | Duloxetine is an antidepressant from the group of selective serotonin-noradrenalin reuptake inhibitors (SSNRIs). It is also used for the treatment of diabetic polyneuropathy and stress incontinence. The side effect spectrum is typical of SSRIs. |
| Accredited | ja |
More Results for the letter D
- D-dimers (FSP)
- Fibrin split products
- DDE/DDT (DDT)
- Dengue-virus infection (DENGUE)
- Arboviruses
- Dermatophyte infection (DERM)
- skin mycosis: superficial and deep Trichophyton infections; Microsporon - superficial infections; Epidermophyton infections
- Dermatophytes infection (MDERM)
- Skin fungus, onychomycosis, tinea
- Desipramine (DES)
- Desoxycortisol (11-) (11D)
- DHEAS (DHEA)
- Dehydroepiandrosterone-sulfate
- Diamine oxidase (DAO)
- Diazepam (DIAZ)
- Dibucaine number (DIBUC)
- Cholinesterase variants
- Digitoxin (DIGI)
- Digoxin (DIGO)
- Dihydrocodeine (DIHYD)
- Diphenhydramine (HPLC) (DIPHHY)
- Diphtheria (DIPH)
- Corynebacterium diphtheriae
- Diphyllobothrium latum (APARA)
- Fish tapeworm
- DNA antibodies (DNAA)
- Donath-Landsteiner antibodies (KAEA37)
- Paroxysmal cold hemoglobinuria
- Doxepin (DOX)
- DPD gene analysis (DPDG)
- Dihydropyrimidine dehydrogenase
- DPD-gene analysis (DPD)
- Dihydropyrimidine dehydrogenase
- Drinking water, analysis (DRIN)
- Drug screening in hair (HAARM)
- Drug screening in saliva (SPEIL)
- Drug screening in urine (DRU1-3)
- Duloxetine (DULO)
- Dysbacteria (DYSB)